Fig. 5.8 Evaluation scores.
Each evaluation criterion can be given a maximum of 1 point (factors 1 and 2 in Table 5 .4) or 2 points (factors 3−5 in Table 5 .4). A maximum total score of 8 is possible. The total number of points defines the MRM-BIRADS. Table 5 .2 lists criteria in contrast-enhancing MR mammography that strongly indicate the presence of malignancy or are unspecific.
Criteria of Malignancy
Unifactorial evaluation protocols that take only one threshold parameter into consideration (e.g., signal increase 90 % in the first minute after CM administration, or increase in normalized units 500) have a significantly lower specificity at an equivalent sensitivity than do multifactorial evaluation protocols (Table 5. 3).
Evaluation Score
It is very helpful for the evaluation of lesions to use a multifactorial protocol in which each evaluation criterion receives a point value. Using the system presented in Table 5 .4, findings with a total score of less than 3 points generally correspond to benign lesions, whereas a total score greater than 3 points indicates malignancy (Fig. 5.8) . Such a scoring system facilitates the differentiation of contrast-enhancing lesions in MR mammography (Figs. 5.9−5.11).
Clinical, mammographic, and ultrasonographic findings must always be integrated in the overall evaluation of a lesion (see Chapter 12). 
General information

Incidence:
Most common benign breast tumor (ȁ10 % of all women). Age peak:
All ages, peak between 20 and 50 years.
Risk of malignant transformation:
Very low (factor 1.3−1.9).
Multifocality:
10−15 %.
Findings
Clinical:
Well-circumscribed, movable, painless mass.
Mammography:
Well-circumscribed, homogeneously dense lesion (round, oval, or lobulated), possible halo sign. Endotumoral popcorn macrocalcifications (2 mm). Cave: Endotumoral or peritumoral pleomorphic microcalcifications (differential diagnosis: carcinoma).
Ultrasonography:
Well-circumscribed, oval lesion with homogeneous internal echo texture. Moderate to strong posterior acoustic enhancement, possible bilateral acoustic shadowing.
Macrocalcifications may cause complete posterior acoustic extinction. Compressibility of lesion: slight to good, depending on histological composition.
Clinical significance
Fibroadenomas must be differentiated from well-defined malignant tumors, especially in older women. If there is uncertainty about the histology, further diagnostic procedures are indicated to rule out malignancy (e.g., percutaneous biopsy). Ultrasound shows well-circumscribed, oval lesion with homogeneous internal echo texture and narrow bilateral posterior shadowing.
Fig. 8.9 Fibroadenoma within parenchyma.
Difficult detection of fibroadenoma due to only slightly lower signal intensity of lesion (arrows) compared to surrounding parenchyma in T1-weighted precontrast image. 
MR mammography: Fibroadenoma
T2-weighted sequence
Signal behavior is dependent upon the histological composition of the fibroadenoma: When a high proportion of epithelial tissue is present (more often in younger women), signal intensity is often high, making the differentiation from a cyst difficult (Fig. 8.11 ). Occasionally endotumoral septations, correlating to fibrotic tumor components, are seen (Note: The selection of a wide window is important!). When a high proportion of the tumor is fibrotic (more often seen in older women), the fibroadenoma is usually not detectable because of the isointensity or slight hypointensity of the signal in comparison to the surrounding parenchyma ( Fig. 8.12 ). 
T1-weighted sequence (contrast-nhanced)
The signal behavior of a fibroadenoma after contrast administration is dependent upon the histological composition of the tumor:
Tumors with a high proportion of epithelial tissue (more frequent in younger women) show pronounced contrast enhancement. The strong initial contrast enhancement (up to several hundred percent of precontrast value) occasionally reaches values higher than those found in many malignant tumors. The postinitial signal usually displays a continuous increase or plateau. A wash-out phenomenon is extremely rare (1 % in our collective). Endotumoral septations with slight CM uptake represent linearly distributed fibrotic tumor portions (see Fig. 8.17) . In rare cases, a nonenhancing peripheral border is seen as the expression of a pseudocapsular demarcation (MR equivalent of halo sign) (see Fig. 8 .16).
Tumors with high proportion of fibrotic tissue (more often in older women) (Fig. 8.13) show no or slight CM uptake. There is correspondingly no or slight contrast enhancement after contrast administration with no or continuous postinitial signal increase during the examination. Differentiation from carcinoma is usually unproblematic.
Fibroadenoma
Medullary Carcinoma
The histopathological features that define the typical form of medullary carcinoma are a tendency for tumor cells to grow in broad sheets without distinct cell borders (syncytial pattern), high nuclear grade (pleomorphic nuclei with prominent nucleoli, usually accompanied by a high mitotic rate), circumscribed tumor margins, and an intense lymphoplasmacytic reaction around and within the tumor. Carcinomas that have most, but not all, of these microscopic features are referred to as atypical medullary carcinomas. The median size of medullary carcinomas is 2−3 cm. Lesions larger than 5 cm tend to show central tumor necrosis and calcification (Figs. 9.21−9.23).
General information
Incidence:
Rare. Less that 10 % of all mammary carcinomas. Often associated with BRCA gene.
Age peak:
All ages; usually under 50 years Prognosis:
Typical form: more favorable than that of invasive ductal carcinoma. Atypical form: identical with that of invasive ductal carcinoma.
Findings
Clinical:
Well-circumscribed tumor.
Mammography:
Well-circumscribed, round or lobulated mass. Occasionally partially ill-defined borders due to lymphocytic infiltrates.
Ultrasonography:
Well-circumscribed, rounded hypoechoic lesion.
Clinical significance
Medullary carcinoma has a special significance within the group of malignant mammary tumors because its typical form is occasionally difficult to differentiate from solid benign tumors of the breast (e.g., fibroadenoma). 
MR mammography: Medullary carcinoma
T1-weighted sequence (precontrast)
Well-circumscribed, hypointense lesion, difficult to detect when located within parenchyma.
T2-weighted sequence
In comparison to breast parenchyma, lesion shows similar or slightly lower signal intensity. Occasional exhibition of peritumoral hyperintense edematous zone.
T1-weighted sequence (contrast-enhanced)
Round or ovoid lesion displaying a contrast enhancement pattern typical of malignancy. Occasional demonstration of ring-enhancement. Signal analysis usually shows moderate to strong initial contrast enhancement. Rare lesions display only slight initial contrast enhancement. In the postinitial phase a plateau is most frequently seen; less frequently one finds a wash-out phenomenon. A continuous signal increase in the postinitial phase is very rare. 
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Other Tumor Forms
Inflammatory Carcinoma
Inflammatory carcinoma does not constitute a histological type but rather a clinical entity (Figs. 9.33−9.35).
Microscopically there is a diffuse infiltration of the skin and mammary tissue, usually by a poorly differentiated infiltrating duct carcinoma. The striking clinical manifestation of inflammatory carcinoma is erythema and edema usually involving more than one-third of the breast skin. In ȁ80 % of cases one finds tumor cells within the dilated dermal lymphatic channels.
General information
Incidence:
Rare (1−2 % of all mammary carcinomas).
Age peak:
40−60 years.
Bilaterality:
Relatively high (reports up to 30 %).
Prognosis:
Very bad. Most aggressive form of all mammary carcinomas.
Findings
Clinical (method of choice):
Erythema. Edema. Hyperthermia. Pain. Diffusely increased firmness. Enlarged skin pores, peau d'orange, cancer en cuirass, tumor fixation. Often enlarged axillary lymph nodes (due to metastases).
Mammography:
Skin thickening. Increased density of parenchyma (note asymmetry!). Occasionally diffuse pleomorphic microcalcifications. Circumscribed mass visible in only one-third of cases.
Ultrasonography:
Skin thickening, interstitial fluid collections (note asymmetry!).
Clinical significance
Inflammatory carcinoma is very difficult to distinguish from nonpuerperal mastitis clinically, as well as with breast imaging techniques. Biopsy of the skin is, therefore, one of the first diagnostic procedures performed to make this distinction. 
